G951-0209 Screening compound: 7-(4-methylphenyl)-5-[4-(propan-2-yl)phenyl]-4H,5H,6H,7H-[1,2,3,4]tetrazolo[1,5-a]pyrimidine

G951-0209 Screening compound: 7-(4-methylphenyl)-5-[4-(propan-2-yl)phenyl]-4H,5H,6H,7H-[1,2,3,4]tetrazolo[1,5-a]pyrimidine
G951-0209 Screening compound: 7-(4-methylphenyl)-5-[4-(propan-2-yl)phenyl]-4H,5H,6H,7H-[1,2,3,4]tetrazolo[1,5-a]pyrimidine alternative view

Chemical Structure Depiction of ChemDiv screening compound G951-0209
7-(4-methylphenyl)-5-[4-(propan-2-yl)phenyl]-4H,5H,6H,7H-[1,2,3,4]tetrazolo[1,5-a]pyrimidine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G951-0209

Molecular Formula

C20H23N5 (C20 H23 N5)

Compound Name

7-(4-methylphenyl)-5-[4-(propan-2-yl)phenyl]-4H,5H,6H,7H-[1,2,3,4]tetrazolo[1,5-a]pyrimidine

IUPAC name

(5S7R)-7-(4-methylphenyl)-5-[4-(propan-2-yl)phenyl]-4H5H6H7H-[1234]tetrazolo[15-a]pyrimidine

SMILES

CC(C)c1ccc([C@@H](C2)Nc3nnnn3[C@@H]2c2ccc(C)cc2)cc1

InChI

InChI=1S/C20H23N5/c1-13(2)15-8-10-16(11-9-15)18-12-19(17-6-4-14(3)5-7-17)25-20(21-18)22-23-24-25/h4-11,13,18-19H,12H2,1-3H3,(H,21,22,24)/t18-,19-/m0/s1

InChI Key

FKTRJMASJLQAGW-OALUTQOASA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

333.44

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

4.827

Distribution Coefficient, logD

4.827

Water Solubility, LogSw

-4.48

Polar Surface Area

53.546

Acid Dissociation Constant (pKa)

15.70

Base Dissociation Constant (pKb)

-0.77

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

35.00

G951-0209 in Drug Discovery

Included in Screening Libraries

3D Mimetics PPI Library (1617 compounds)

Anti-infective Library (19449 compounds)

Antiviral HBV Library (10007 compounds)

Protein-Protein Interaction Library (218420 compounds)

Akt-Targeted Library (14764 compounds)

Epigenetics Focused Set (26518 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

Included in 1.7M Stock Database

Structure:
  • Mimetics
  • 3D
Therapeutical areas:
  • Infections
  • Immune system
  • animal
  • Antiviral
  • Infections
  • Immune system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Mechanism of action:
  • PPI modulators
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with G951-0209 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G951-0209?
Check Price and Availability of G951-0209, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G951-0209 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G951-0209
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G951-0209
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G951-0209 available by request